Moving Toward Integrated Behavioral Intervention for Treating Multimorbidity Among Chronic Pain, Depression, and Substance-use Disorders in Primary Care

Medical Care ◽  
2014 ◽  
Vol 52 (4) ◽  
pp. 322-327 ◽  
Author(s):  
Jeffrey P. Haibach ◽  
Gregory P. Beehler ◽  
Katherine M. Dollar ◽  
Deborah S. Finnell
2012 ◽  
Vol 2012 ◽  
pp. 1-7 ◽  
Author(s):  
Leah Zallman ◽  
Sonia L. Rubens ◽  
Richard Saitz ◽  
Jeffrey H. Samet ◽  
Christine Lloyd-Travaglini ◽  
...  

Attitudinal barriers towards analgesic use among primary care patients with chronic pain and substance use disorders (SUDs) are not well understood. We evaluated the prevalence of moderate to significant attitudinal barriers to analgesic use among 597 primary care patients with chronic pain and current analgesic use with 3 subscales from the Barriers Questionaire II: concern about side effects, fear of addiction, and worry about reporting pain to physicians. Concern about side effects was a greater barrier for those with opioid use disorders (OUDs) and non-opioid SUDs than for those with no SUD (OR (95% CI): 2.30 (1.44–3.68), P<0.001 and 1.64 (1.02–2.65), P=0.041, resp.). Fear of addiction was a greater barrier for those with OUDs as compared to those with non-opioid SUDs (OR (95% CI): 2.12 (1.04–4.30), P=0.038) and no SUD (OR (95% CI): 2.69 (1.44–5.03), P=0.002). Conversely, participants with non-opioid SUDs reported lower levels of worry about reporting pain to physicians than those with no SUD (OR (95% CI): 0.43 (0.24–0.76), P=0.004). Participants with OUDs reported higher levels of worry about reporting pain than those with non-opioid SUDs (OR (95% CI): 1.91 (1.01–3.60), P=0.045). Concerns about side effects and fear of addiction can be barriers to analgesic use, moreso for people with SUDs and OUDs.


2013 ◽  
Vol 127 (1-3) ◽  
pp. 243-247 ◽  
Author(s):  
Jonathan D. Savant ◽  
Declan T. Barry ◽  
Christopher J. Cutter ◽  
Michelle T. Joy ◽  
An Dinh ◽  
...  

2020 ◽  
Vol 35 (4) ◽  
pp. 1111-1119 ◽  
Author(s):  
Mikko Sayre ◽  
Gwen T. Lapham ◽  
Amy K. Lee ◽  
Malia Oliver ◽  
Jennifer F. Bobb ◽  
...  

Author(s):  
Michael F. Weaver

In conjunction with chapters 16 and 17, which described non-pharmacological approaches to pain management, this chapter reviews the available non-pharmacological approaches to substance use disorders (SUD). Specific subtopics include 12-Step programs and facilitation, motivational enhancement therapy, cognitive behavioral therapy, individual and group psychotherapies, contingency management, community reinforcement, family therapy, relapse management, and the terminal consideration of all therapies, termination (what is the duration of treatment)? Each subtopic is addressed in abstract rather than in comprehensive format, to allow the primary care provider to identify her level of interest and present level of understanding, and to inform further reading. The chapter concludes with a text box providing additional resources.


2020 ◽  
pp. 1-6
Author(s):  
Nadine R. Taghian ◽  
R. Kathryn McHugh ◽  
Margaret L. Griffin ◽  
Alexandra R. Chase ◽  
Shelly F. Greenfield ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document